COPD Management

Selected news for the healthcare topic - COPD Management, collected since 10/2017. We are still establishing shared news links for this healthcare topic.

Please provide a valid email address.
Shares Healthcare News With (link):
Healthcare Topics

Selected Headlines

Date Headline (link) Source Relevant Snippet
10/20/2021 Biomarker discovery may lead to better treatments for asthma, COPD, Rutgers researchers say - The News Yard thenewsyard.com ... medicine at Rutgers.“In addition to identifying this protein, we demonstrated that if you decrease the leakage, the smooth muscles in the airways relax, which could be potentially very important in improving asthma and COPD management. In addition, the presence of too much cAMP in a patient’s blood is a new biomarker that can help characterize specific types of asthma and COPD.”About 25 million U.S. residents have ...
9/24/2021 Pulmonary Drug Delivery Systems Market Latest Study, Development Status, Opportunities, Future Plans, and Forecast to 2027 PRSync ... All Related Graphs & Charts: ttps://www.coherentmarketinsights.com/insight/request-sample/3952 Market Trends The market is witnessing the launch of digital inhalers. For instance, FindAir, a European company that develops automated systems for asthma and COPD management, unveiled its commercial smart inhaler product FindAir ONE in January 2019. Major players in the market are focused on the approval and launch of new devices to expand their product portfolio. For instance, Novartis ...
9/9/2021 Targeting exertional breathlessness to improve physical activity: the role of primary care Nature ... decline in capacity to perform it, further impacts the management of the disease. Improving patient tolerance of physical activity, increasing participation in daily activities and helping patients to remain active are clear goals of COPD management. These may require an holistic approach to management, including pulmonary rehabilitation and psychological programmes in parallel with bronchodilation therapy, in order to address both physiological and behavioural factors. PCPs have an important role to ...
7/28/2021 Impacts of lipid-related metabolites, adiposity, and genetic background on blood eosinophil counts: the Nagahama study Nature Abstract Blood eosinophil count is a useful measure in asthma or COPD management. Recent epidemiological studies revealed that body mass index (BMI) is positively associated with eosinophil counts. However, few studies focused on the role of adiposity and fatty acid-related metabolites on eosinophil counts, including the effect of genetic polymorphism. In this community-based study involving 8265 participants (30–74 year old) from Nagahama city, we investigated the relationship ...
7/21/2021 Evaluating the implementation of a chronic obstructive pulmonary disease management program using the Consolidated Framework for Implementation Research: a case study biomedcentral.com ... it accounts for a significant portion of Canada’s annual healthcare spending. Interprofessional teams are effective at providing chronic disease management that meets the needs of patients. As part of an ongoing initiative, a COPD management program, the Best Care COPD program was implemented in a primary care setting. The objectives of this research were to determine site-specific factors facilitating or impeding the implementation of a COPD program in ...
5/14/2021 COPD Case-Finding Tool Validated, Ready for Use in Primary Care pulmonologyadvisor.com ... 2021. Researchers conducted the CAPTURE validation study by using a multimethod qualitative approach to guide longitudinal assessments and to inform strategies for implementation of the CAPTURE tool. Continue ReadingRecognizing that the enhancement of COPD management should include optimal disease identification at the primary care level, the researchers performed a thorough qualitative review of the CAPTURE tool in US primary care practice. The CAPTURE validation study included workflow reviews, patient ...
5/7/2021 Exploring the Use of Omics to Eliminate Sex and Gender Differences in COPD pulmonologyadvisor.com ... clinical phenotypes. 1 However, there have not been accompanying strides in the development of novel therapies tailored to the needs of various patient groups, which has hindered progress toward a precision medicine approach in COPD management.The exploration of biomarker-based targeted treatment strategies for COPD would benefit exponentially from the use of large-scale “Omics” — namely, genomic, epigenomic, transcriptomic, proteomic, and metabolomic data. Realizing the true value ...
5/4/2021 A Closer Look at a Team-Based Approach to Improve COPD Symptoms Physicians Weekly ... all these factors in the context of managing other chronic diseases and acute care issues during a standard 15-to-20–minute primary care provider (PCP) office visit.” The Team-Based Approach to COPD Management For a study published in the Journal of the American Board of Family Medicine , Dr. Peckens and colleagues at the West Virginia University Department of Family Medicine evaluated a team-based approach they implemented ...
4/21/2021 Helping Older People Breathe More Easily - PubMed National Institutes of Health ... priority. Moreover, in the same report, high rates of comorbidities such as dyslipidaemia, hypertension, heart disease, and cancer are noted, along with increasing emergency department presentations and increasing expenditure on drug therapy used for COPD management. [x ...
11/30/2020 Factors Affecting Community Pharmacist's Knowledge About Chronic Obstructive Pulmonary Disease (COPD) Management in China: A Cross-Sectional Survey Study dovepress.com ... public health. Many studies have confirmed that the professional services for COPD patients by community pharmacists can improve comprehensive benefits. However, there’s less research investigating the factors affecting community pharmacists’ knowledge about COPD management. Therefore, this study aimed to investigate the knowledge of COPD among community pharmacists in China and analyze the factors affecting community pharmacist’s knowledge about COPD management. Methods: This study employed a face-to ...
11/20/2020 National health groups offer support for COPD patients and caregivers amid pandemic news-medical.net ... and out of the hospital, especially for those living with COPD, which is already a high-risk disease for readmissions to the hospital.” Byron Thomashow, M.D, Chief Medical Officer, COPD Foundation Questions about COPD management in the COVID era?The Centers for Disease Control and Prevention (CDC) has identified those living with COPD among those at greater risk for the most severe complications from COVID-19. To protect their ...
11/19/2020 The caregiver difference: One man’s journey caring for his father’s COPD ask.com ... as part of the support system.A new survey from GSK conducted in collaboration with CHEST and COPD Foundations identified significant gaps in communication between patients and their doctors, which create barriers to optimal COPD management. The survey, which was fielded to 351 people with COPD, 151 caregivers, 249 primary care physicians and 252 pulmonologists, found that caregivers play a valuable role in bridging these gaps and positively impact care ...
9/17/2020 Clear Arch Health Expands Device Ecosystem to Ensure Timely Clinical Touchpoints and Support for COVID-19 and COPD Management PR Newswire ... manage high-risk patient populations and those who may be delaying their care. Clear Arch Health announced today the addition of new connected health devices to ensure timely clinical touchpoints for COVID-19 and COPD management. The new peripherals complement the company’s already rich ecosystem of connected health devices and will provide clinical teams access to patient generated health data to better manage high-risk patient populations and those who ...
9/17/2020 Clear Arch Health Expands Device Ecosystem to Ensure Timely Clinical Touchpoints and Support for COVID-19 and COPD Management tmcnet.com FREE eNEWSLETTERS TMCnet News Clear Arch Health Expands Device Ecosystem to Ensure Timely Clinical Touchpoints and Support for COVID-19 and COPD Management [September 17, 2020] Clear Arch Health Expands Device Ecosystem to Ensure Timely Clinical Touchpoints and Support for COVID-19 and COPD Management BOCA RATON, Fla. , Sept. 17, 2020 /PRNewswire/ -- Clear Arch Health , a leading provider of remote patient monitoring (RPM) and mobile personal emergency response system (mPERS ...
9/1/2020 Bilim Pharmaceuticals, H&T Presspart and Hovione Collaborate contractpharma.com ... a pharmaceutical specialist in the development of innovative pulmonary device technology, are collaborating to support Bilim Pharmaceutical’s launch into the Turkish market of Ventofor Combi Fix, a formulation of Budesonide Formoterol for Asthma and COPD management, delivered by the PowdAir Plus Dry Powder Inhaler (DPI). Treating Asthma in Turkey Worldwide over 500 million people suffer from Asthma and COPD. In Turkey, there is growing patient demand for effective, readily accessible ...
8/11/2020 Zhongchao Inc. Develops Live Interactive Courses Promoting the Global Initiative for Chronic Obstructive Lung Disease PR Newswire ... a global initiative to raise awareness of chronic obstructive pulmonary disease ("COPD") and to improve prevention and treatment of this lung disease for patients around the world. GOLD's primary objectives include: i) Recommend effective COPD management and prevention strategies for use in all countries; ii) Increase awareness of the medical community, public health officials and the general public that COPD is a public health problem; iii) Decrease morbidity and mortality ...
8/11/2020 Zhongchao Inc. Develops Live Interactive Courses Promoting the Global Initiative for Chronic Obstructive Lung Disease BioSpace ... a global initiative to raise awareness of chronic obstructive pulmonary disease ("COPD") and to improve prevention and treatment of this lung disease for patients around the world. GOLD's primary objectives include: i) Recommend effective COPD management and prevention strategies for use in all countries; ii) Increase awareness of the medical community, public health officials and the general public that COPD is a public health problem; iii) Decrease morbidity and mortality ...
6/25/2020 Breztri Aerosphere Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial drugs.com ... support the strong clinical profile of Breztri Aerosphere in reducing exacerbation rates compared with dual-combination therapies. We are excited to have the data on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of Breztri Aerosphere were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported adverse events were nasopharyngitis, COPD and upper respiratory tract infection ...
6/25/2020 PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial financialbuzz.com ... trial support the strong clinical profile of PT010 in reducing exacerbation rates compared with dual-combination therapies. We are excited to have the data on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of PT010 were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported adverse events were nasopharyngitis, COPD and upper respiratory tract infection. The ...
6/24/2020 PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial BioSpace ... trial support the strong clinical profile of PT010 in reducing exacerbation rates compared with dual-combination therapies. We are excited to have the data on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of PT010 were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported adverse events were nasopharyngitis, COPD and upper respiratory tract infection. The ...